Attached files

file filename
10-K - ADMA BIOLOGICS, INC.e615811_10k-adma.htm
EX-32.2 - ADMA BIOLOGICS, INC.e615811_ex32-2.htm
EX-32.1 - ADMA BIOLOGICS, INC.e615811_ex32-1.htm
EX-31.2 - ADMA BIOLOGICS, INC.e615811_ex31-2.htm
EX-31.1 - ADMA BIOLOGICS, INC.e615811_ex31-1.htm
EX-10.22 - ADMA BIOLOGICS, INC.e615811_ex10-22.htm

 

Exhibit 23.1

 

Consent of Independent Registered

Public Accounting Firm

 

We consent to the incorporation by reference in the registration statements on Form S-8 (File Nos. 333-193635 and 333-204590) and Form S-3 (File No. 333-200638) filed by ADMA Biologics, Inc. of our report, which includes an explanatory paragraph relating to the Company’s ability to continue as a going concern, dated February 24, 2017, on our audits of the consolidated financial statements of ADMA Biologics, Inc. and Subsidiaries as of December 31, 2016 and 2015 and for the years then ended, included in this Annual Report on Form 10-K of ADMA Biologics, Inc. for the year ended December 31, 2016.

 

/s/ CohnReznick LLP

 

Roseland, New Jersey

February 24, 2017